Metilmetioninsulfoniya chloride in the complex of therapeutic and prophylactic programs at diseases of gastroduodenal zone
https://doi.org/10.21518/2079-701X-2019-3-60-68
Abstract
The management of patients in remission, rehabilitation after treatment of inflammatory and erosive-ulcerative lesions of gastroduodenal zone in spite of actively used schemes antihelikobakterna therapy require additional discussions regarding the issue of cytoprotective. The article substantiates the importance of the inclusion in the complex therapy of these diseases S-methylmethanesulfonamide ( vitamin U). The data of experimental and clinical studies, indicating the protective properties and clinical efficacy of this drug. The possibility of drug astrorex containing the active substance S-methylmethane to improve the course of disease, faster relief of symptoms, long disease-free. Pharmacological preparations containing vitamin U in their composition can be used in a complex of medical, preventive and rehabilitation programs with active participation and sufficient compliance in the implementation of these programs by the patient.
About the Authors
N. V. Topchiy
Federal State Budgetary Educational Institution of Additional Professional Education «Russian Medical Academy of Continuing Professional Education» of the Ministry of Health of the Russian Federation;
All-Russian Public Organization «Association of General Practitioners (Family Practitioners) of the Russian Federation»;
Russian Gastroenterological Association
Russian Federation
Russian Federation
Cand. of Sci. (Med.), doсent, gastroenterologist, doсent of the Department of General medical practice and polyclinic therapy, 125993, Moscow, Barrikadnaya St., 2/1, b. 1;
member of the Association of General practitioners (family doctors) of the Russian Federation, 119992, Moscow, B. Pirogovskaya St., 2/6;
member of the Russian gastroenterological Association, 119881, Moscow, Pogodinskaya St., 1, Bldg. 1
A. S. Toporkov
Federal State Budgetary Educational Institution of Additional Professional Education «Russian Medical Academy of Continuing Professional Education» of the Ministry of Health of the Russian Federation;
All-Russian Public Organization «Association of General Practitioners (Family Practitioners) of the Russian Federation»;
Russian Gastroenterological Association
Russian Federation
Russian Federation
Cand. of Sci. (Med.), gastroenterologist, member of the Russian gastroenterological Association,
References
1. Ivashkin V.T., Sheptulin A.A., Maev I.V. et al. Clinical guidelines of the Russian Gastroenterological Association for diagnosis and treatment of peptic ulcer. RJGGT. 2016;26(6):40-54. (In Russ.)
2. Maev I.V., Samsonov A.A., Andreev N.G., Andreev D.N. Important practical results and current trends in the study of diseases of stomach and duodenum. Ros. Journal. Gastroenterol., Hepatol. I Koloproktol. 2012;4:17-26. (In Russ.)
3. Ivashkin V.T., Maev I.V., Lapina T.L. The Russian Gastroenterological Association clinical guidelines for diagnosisand treatment of Helicobacter pylori infectionin adults. RJGGK. 2018;28(1):55–77. (In Russ.)
4. Bordin D.S., Masharova A.A., Khomeriki S.G. Chronic gastritis: a modern view of the old problem. Experimentalnaya i Klinicheskaya Gastroenterologiya. 2012;5:99-106. (In Russ.)
5. Lau J.Y., Sung J., Hill C. et al. Systematic review of the epidemiology of complicated peptic ulcerdisease: incidence, recurrence, risk factors and mortality. Digestion, 2011;84:102-113.
6. Yakovenko E.P., Ivanov A.N., Illarionova Yu.V. et al. Chronic gastritis: diagnosis and treatment. Pharmateca. 2009;8:50-54. (In Russ.)
7. Zimmerman Ya.S. Peptic ulcer: actual problems of aetiology, pathogenesis, differentiated treatment. In the book: Unsolved and Controversial Problems of Modern Gastroenterology. М.: MEDpress-inform, 2013:85-107. (In Russ.)
8. Deding U., Ejlskov L., Grabas M.P.K., Nielsen B.J., Torp-Pedersenand C., Bøggild H. Perceived stress as a risk factor for peptic ulcers:a register-based cohort study. BMC Gastroenterology. 2016;16:140. doi: 10.1186/s12876-016-0554-9.
9. Pakhomova I.G. Potential use of methylmethioninesulfoniumchloride as a component of combination therapy for peptic ulcer and gastroduodenitis. Meditsinsky Sovet. 2018;14:28-32. (In Russ.)
10. Ivashkin V.T., Mayev I.V., Ivashkin K.V., Korochanskaya N.V., Lopina О.D., Lapina T.L., Poluektova Ye.A., Rumyantseva D.Ye., Simanenkov V.I., Trukhmanov A.S., Khlynov I.B., Sheptulin A.A. (Expert Advisory Body Resolution, March 12–13, 2016) The role of violation of protective factors in the development of acidrelated diseases. RJGGK. 2016;3:115-116. (In Russ.)
11. Asha D., Patel A.D., Prajapati N.K. Review on Biochemical Importance of Vitamin U. J Chem Pharm Res. 2012;4(1):209–215.
12. Nesterova A.P., Taits N.S. Experienceofusing Vitamin U in the complex treatment ofpeptic ulcer. Institute of Nutrition of the Academy of Medical Sciences of the USSR. Vitamin U (S-Methylmethionine) Origin, properties, use. М.: Nauka, , 1973: 53-60. (In Russ.)
13. Watanabe T., Ohara S., Ichikawa T., Saigenji K., Hotta K. Mechanismsfor cytoprotection by vitamin U from ethanol-induced gastricmucosal damage in rats. Dig Dis Sci. 1996 Jan;41(1):49–54.
14. The Photoprotective Effect of S-Methylmethionine Sulfonium in Skin/ Won-Serk Kim, Hyun-Min Seo, Wang-Kyun Kim et al. Sunglnt. J. Mol. Sci. 2015;16:17088–17100.
15. Golovanova E.S. Clinical effect and analysis of some aspects of the mechanism of action of the domestic vitamin U (S-methylmethionine) in peptic ulcer. Perm, 1974 (In Russ.)
16. Patel A.D., Prajapati N.K. Review on Biochemical Importance of Vitamin-U. Journal of Che mical andPharmaceutical Research. 2012;4(1):209-215.
17. Anisimov V.E. et al. The effectiveness of the use of domestic vitamin U in gastric ulcer and duodenal ulcer. Vitamin U (S - Methylmethionine) Nature, properties, application. M.: Nauka, 1973:64–71. (In Russ.)
18. Na Young Lee, Kui Young Park, Hye Jung Min et al. Inhibitory Effect of Vitamin U (S-Methylmethionine Sulfonium Chloride) on Differentiation in 3T3-L1 Pre-adipocyte. Cell Lines Ann Dermatol. 2012;24(1):49–54.
19. Tunali S., Kahraman S., Yanardag R. Vitamin U, a novel free radical scavenger, prevents lens injury in rats administered with valproic acid. Hum Exp Toxicol.2015 Sep.;4(9):904–910.
20. Seri K., Matsuo T., Taniguchi T., Amemiya K., Kudo M., Saito G., Kato T. Hypolipidemic effects of S-methylmethionine (vitamin U) using arious experimental procedures. Arzneimittelforschung. 1980;30(10):1694–1703.
21. Seri K., Matsuo T., Asano M., Sato R., Kato T. Mode of hypocholesterolemic action of S-methylmethionine (vitamin U) in mice. Arzneimittelforschung. 1979;29(12):1857–1858.
22. Matsuo T., Seri K., Kato T. Comparative effects of S-methylmethionine (vitamin U) and methionine on choline-deficient fatty liver in rats. Arzneimittelforschung. 1980;30(1):68–69.
23. Nakamura N., Uzawa H., Kanazawa K., Tamai Y., Tashiro Y., Koide M. Hypolipidemic effect of L-form S-methylmethionine sulfonium chloride in man. Arzneimittelforschung. 1981;31(4):725– 729.
24. Cheney G. Effect of diet and cinchophen on production of experimentalgastric ulcers in chicks. Proc. Soc. Exper. Biol. & Med. 1040;45:190.
25. Cheney G. Cinchophen gastric ulcers in chicks. Arch. Int. Medl. 1942;70:532.
26. Cheney G. Prevention of histamine – indluced peptic ulcers by diet. Stanford M. Bull. 1948;6:334.
27. Cheney G. Rapid healing of peptic ulcers in patient sreceiving freshcabbage juice. Calif. Med. 1949;70:10231–236.
28. Cheney G., Waxler S.H., Miller I.J. Vitamin U therapy of peptic ulcer. Experience at San Quentin. Prison California Medicine. 1956;84(1):39–42.
29. Chan H.L., Wu J.C., Chan F.K. et al. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospectivestudy of 977 patients. Gastrointest Endosc. 2001;53:438–442.
30. Wurzel G. Arztl. Praxis.1969;8:14.
31. Drozdov V.N., Shikh E.V., Starodubtseva A.K., Smolyarchuk E.A. Chronic gastritis and idiopathic peptic ulcer, the prospects for the use of S-methylmethionine (vitamin U) in complex therapy. Trudny Patsient. 2018;6(16):12-18. (In Russ.)
32. Yamagata S., Takahasu S., Sato M., Nakatori T., Bytasu U. Библиограф. сборник. 1965; 2.
33. Nakamura U., Hirobasi T., Bytasu U. Библиограф. сборник.1965; 2.
34. Samson E.I., Chernobrobyj V.N., Likhachev V.A. Issues of prevention, diagnosis and treatment of the digestive system diseases. Chernivtsi, 1970 (In Russ.)
35. Samson E.I., Lukanev G.D. Therapeutic efficacy of vitamin U with ulcers. Perm State Medical Institute. Vitamin U (S-Metilmetionin) nature, properties, application. M.: Nauka, 1973:96-101. (In Russ.)
36. Sato K. J. Clin. and Exp. Med. 1956;36:1139.
37. Suzue R. Bull. Inst. Chem. Res. Kyoto Univ. 1967;45:201.
38. Meshcherskaya K.A. Farmakologiya i toksikologiya. 1954;17(5):26. (In Russ.)
39. Ichikawa T., Ito Y., Saegusa Y., Iwai T., Goso Y., Ikezawa T., Ishihara K. Author information Effects of combination treatment with famotidine and methylmethioninesulfonium chloride on the mucus barrierof rat gastric mucosa. J Gastroenterol Hepatol. 2009;24(3):488–492.
40. Mansurov H.H., Pinhasov I.I. Результаты клинического испытания витамина U при язвенной болезни и хроническом гастрите. Витамин U (S-метилметионин). Природа свойства применение. М.: Наука, 1973:53–60. (In Russ.)
41. Frank Yu.P., Korzhukova P.I. The use of vitamin U in patients with duodenal ulcer and chronic gastritis. Duodenal ulcer (pathogenesis, diagnosis, treatment). M.:1981:110–116. (In Russ).
42. Dietology. Guide. 5th ed. Under the editorship of A.Yu. Baranovsky. SPb: Peter, 2017. 1104 p. (In Russ).
43. Tikhonov S.V. Predictors of low treatment compliance in patients with gastroesophageal reflux disease. Bulletin of Saint Petersburg state Pavlov medical university. 2013;20(3):79- 81. (In Russ.)
44. Alekseeva O.P., Kasimova L.N., Goryacheva E.E. Adherence to therapy in patients with gastrointestinal tract pathology. RJGGK. 2016;1:20-28. (In Russ).
45. Kremleva O.V. Problems of noncompliance in somatic clinical manifestations, overcoming technique [Electronic resource]. Meditsinskaya Psikhologiya v Rossii: Elektron. Nauch. Zhurn 2013;4:21 Accessed mode: http://mprj.ru. (In Russ).
46. Kim K.T., Kim J.S., Kim M.-H. et al. Effect of Enhancers on in vitro and in vivo Skin Permeation and Deposition of S-Methyl-lMethionine. Biomolecules & Therapeutics. 2017;25(4):434–440. doi: 10.4062/biomolther.2016.254.
Review
For citations:
Topchiy NV, Toporkov AS. Metilmetioninsulfoniya chloride in the complex of therapeutic and prophylactic programs at diseases of gastroduodenal zone. Meditsinskiy sovet = Medical Council. 2019;(3):60-68. (In Russ.) https://doi.org/10.21518/2079-701X-2019-3-60-68
Views:
6152
Email this article 